Phillip Coffin

Behavioral Safety and Fentanyl Education: BSAFE

National Institute on Drug Abuse · R01

Contact PI · $1.3M · Public Health Foundation Enterprises

Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder

National Institute on Drug Abuse · UG3

PI · $2.8M · Ut Southwestern Medical Center

Midcareer K24 Award for Mentoring and Patient-Oriented Research

National Institute on Drug Abuse · K24

Contact PI · $1.6M · San Francisco Department of Public Health

Glutide for Ending Methamphetamine

National Institute on Drug Abuse · UG3

Contact PI · $1.8M · Public Health Foundation Enterprises

Reliability, Validity, and Acceptability of a Novel Visual Scale for Estimating Daily Methamphetamine Use Among People Who Use Methamphetamine

Principal investigator · Not yet recruiting

Phillip Coffin, MD, MIA

Mirtazapine and Methamphetamine Drug-drug Interaction Study

Principal investigator · Completed · Phase 1

San Francisco Department of Public Health

PrEP Intervention for People Who Inject Substances and Use Methamphetamine

Principal investigator · Unknown · Phase 4

San Francisco Department of Public Health

Repeated-dose Behavioral Intervention to Reduce Opioid Overdose

Principal investigator · Completed

San Francisco Department of Public Health